CO107 Progression-Free Survival in Patients with Advanced or Metastatic, Hormone Receptor Positive, HER2-Negative Breast Cancer Treated with Palbociclib in Combination with Fulvestrant: A Real-World Study

GA Matiz,BA Alarcon,JM Reyes Sanchez, D Moran,R Bruges, M Lombana,R Manneh

VALUE IN HEALTH（2022）

引用 0|浏览0

暂无评分

摘要

To evaluate progression free survival (PFS) in patients with advanced or metastatic, hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer treated with palbociclib in combination with fulvestrant as second or later lines of treatment.

查看译文

关键词

breast cancer,palbociclib,fulvestrant,progression-free,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要